creatine has been researched along with Metabolic Syndrome in 11 studies
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effects of canrenone compared to placebo on blood pressure control, some non-conventional biomarkers in cardiovascular stratification, and on metalloproteinases in patients affected by metabolic syndrome." | 9.20 | The effects of canrenone on inflammatory markers in patients with metabolic syndrome. ( Bianchi, L; D'Angelo, A; Derosa, G; Maffioli, P; Romano, D, 2015) |
| " In the present study, the contribution of different variables, such as the presence of metabolic syndrome (MetS), the volume creatinine clearance (V/CrCl) ratio, the iodine-dose (I-dose)/CrCl ratio, or hypertension, to CI-AKI was evaluated." | 7.88 | Metabolic Syndrome and the Iodine-Dose/Creatinine Clearance Ratio as Determinants of Contrast-Induced Acute Kidney Injury. ( Amiri, A; Arab, M; Ghanavati, R; Riahi Beni, H; Sezavar, SH; Sheykhvatan, M, 2018) |
| "To evaluate the effects of canrenone compared to placebo on blood pressure control, some non-conventional biomarkers in cardiovascular stratification, and on metalloproteinases in patients affected by metabolic syndrome." | 5.20 | The effects of canrenone on inflammatory markers in patients with metabolic syndrome. ( Bianchi, L; D'Angelo, A; Derosa, G; Maffioli, P; Romano, D, 2015) |
| " In the present study, the contribution of different variables, such as the presence of metabolic syndrome (MetS), the volume creatinine clearance (V/CrCl) ratio, the iodine-dose (I-dose)/CrCl ratio, or hypertension, to CI-AKI was evaluated." | 3.88 | Metabolic Syndrome and the Iodine-Dose/Creatinine Clearance Ratio as Determinants of Contrast-Induced Acute Kidney Injury. ( Amiri, A; Arab, M; Ghanavati, R; Riahi Beni, H; Sezavar, SH; Sheykhvatan, M, 2018) |
| "Insulin sensitivity was estimated using the homeostatic model assessment index (HOMA-B) for beta cell function and (HOMA-IR) for peripheral tissue insulin resistance." | 1.39 | Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness. ( Abdel-Rasheed, E; El-Fishawy, H; Gheita, TA; Nasrallah, MM; Raafat, HA; Sayed, S, 2013) |
| "Subjects with the metabolic syndrome are significantly more likely to have higher BMI (> 25 kg/m(2)), HbA(1c) [≥ 42 mmol/mol (6." | 1.38 | Predictors of ischaemic heart disease in a Malaysian population with the metabolic syndrome. ( Azwany, YN; Bebakar, WM; Ismail, AA; Ismail, IS; Kamaruddin, NA; Kamarul Imran, M; Khalid, BA; Khir, AS; Md Isa, SH; Mustafa, N; Nazaimoon, WM; Osman, A; Yeow, TP, 2012) |
| "The metabolic syndrome was noted in 16." | 1.35 | Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker. ( Bloomgarden, ZT; Futterweit, W; Patel, AA, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Uema, T | 1 |
| Millman, JF | 1 |
| Okamoto, S | 1 |
| Nakamura, T | 1 |
| Yamashiro, K | 1 |
| Uehara, M | 1 |
| Honma, KI | 1 |
| Miyazato, M | 1 |
| Ashikari, A | 1 |
| Saito, S | 1 |
| Maeda, S | 1 |
| Imamura, M | 1 |
| Ishida, H | 1 |
| Matsushita, M | 1 |
| Nakamura, K | 1 |
| Masuzaki, H | 1 |
| Khan, SH | 1 |
| Shahid, R | 1 |
| Fazal, N | 1 |
| Ijaz, A | 1 |
| Amiri, A | 1 |
| Ghanavati, R | 1 |
| Riahi Beni, H | 1 |
| Sezavar, SH | 1 |
| Sheykhvatan, M | 1 |
| Arab, M | 1 |
| Derosa, G | 1 |
| Romano, D | 1 |
| Bianchi, L | 1 |
| D'Angelo, A | 1 |
| Maffioli, P | 1 |
| Heikkilä, O | 1 |
| Lundbom, N | 1 |
| Timonen, M | 1 |
| Groop, PH | 1 |
| Heikkinen, S | 1 |
| Mäkimattila, S | 1 |
| Hermida, RC | 1 |
| Chayán, L | 1 |
| Ayala, DE | 1 |
| Mojón, A | 1 |
| Domínguez, MJ | 1 |
| Fontao, MJ | 1 |
| Soler, R | 1 |
| Alonso, I | 1 |
| Fernández, JR | 1 |
| Coplan, JD | 1 |
| Abdallah, CG | 1 |
| Mathew, SJ | 1 |
| Shungu, DC | 1 |
| Mao, X | 1 |
| Smith, EL | 1 |
| Kaufman, D | 1 |
| Gorman, JM | 1 |
| Owens, MJ | 1 |
| Nemeroff, CB | 1 |
| Banerji, MA | 1 |
| Rosenblum, LA | 1 |
| Kral, JG | 1 |
| Yeow, TP | 1 |
| Khir, AS | 1 |
| Ismail, AA | 1 |
| Ismail, IS | 1 |
| Kamarul Imran, M | 1 |
| Khalid, BA | 1 |
| Kamaruddin, NA | 1 |
| Azwany, YN | 1 |
| Mustafa, N | 1 |
| Osman, A | 1 |
| Md Isa, SH | 1 |
| Bebakar, WM | 1 |
| Nazaimoon, WM | 1 |
| Gheita, TA | 1 |
| Raafat, HA | 1 |
| Sayed, S | 1 |
| El-Fishawy, H | 1 |
| Nasrallah, MM | 1 |
| Abdel-Rasheed, E | 1 |
| Choe, CU | 1 |
| Nabuurs, C | 1 |
| Stockebrand, MC | 1 |
| Neu, A | 1 |
| Nunes, P | 1 |
| Morellini, F | 1 |
| Sauter, K | 1 |
| Schillemeit, S | 1 |
| Hermans-Borgmeyer, I | 1 |
| Marescau, B | 1 |
| Heerschap, A | 1 |
| Isbrandt, D | 1 |
| Patel, AA | 1 |
| Bloomgarden, ZT | 1 |
| Futterweit, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Some Emerging Biomarkers of Cardiovascular Risk Stratification in Hypertensive Patients: a 5-years Follow-up[NCT02064218] | 0 participants | Observational | 2007-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for creatine and Metabolic Syndrome
| Article | Year |
|---|---|
The effects of canrenone on inflammatory markers in patients with metabolic syndrome.
Topics: Aged; Aldosterone; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Canrenon | 2015 |
10 other studies available for creatine and Metabolic Syndrome
| Article | Year |
|---|---|
Profile of gut microbiota and serum metabolites associated with metabolic syndrome in a remote island most afflicted by obesity in Japan.
Topics: Body Mass Index; Creatine; Gastrointestinal Microbiome; Glycated Hemoglobin; Humans; Insulins; Japan | 2022 |
Comparison of Various Abdominal Obesity Measures for Predicting Metabolic Syndrome, Diabetes, Nephropathy, and Dyslipidemia.
Topics: Anthropometry; Body Mass Index; Creatine; Cross-Sectional Studies; Dyslipidemias; Female; Humans; In | 2019 |
Metabolic Syndrome and the Iodine-Dose/Creatinine Clearance Ratio as Determinants of Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatine; Creatinine; Female; Human | 2018 |
Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism.
Topics: Adult; Anthropometry; Aspartic Acid; Blood Glucose; Choline; Creatine; Diabetes Mellitus, Type 2; Hu | 2008 |
Association of metabolic syndrome and blood pressure nondipping profile in untreated hypertension.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Creatine; Cross-Sect | 2009 |
Metabolic syndrome and neurometabolic asymmetry of hippocampus in adult bonnet monkeys.
Topics: Animals; Aspartic Acid; Blood Glucose; Choline; Corticotropin-Releasing Hormone; Creatine; Functiona | 2011 |
Predictors of ischaemic heart disease in a Malaysian population with the metabolic syndrome.
Topics: Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Cholesterol, LDL; Creatine; Cross-Sectional | 2012 |
Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness.
Topics: Adult; Blood Glucose; Carotid Intima-Media Thickness; Comorbidity; Creatine; Female; Humans; Insulin | 2013 |
L-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome.
Topics: Adenylate Kinase; Adipose Tissue; Amidinotransferases; Animals; Body Weight; Brain; Creatine; Enzyme | 2013 |
Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker.
Topics: Adult; Albuminuria; Biomarkers; Blood Pressure; Creatine; Female; Humans; Metabolic Syndrome; Middle | 2008 |